Acology, Inc. (OTC Pink: ACOL) is engaged in the manufacturing, branding, sales, consulting, and management of smell-proof storage containers. One of the main applications for the technology is for cannabis storage. Shares of the container company jumped 34.81%, through afternoon trading on Monday, February 27, 2017. Over the past three months, Acology, Inc. has seen average daily volume of 22.43 million shares. However, volume of 31.24 million shares or dollar volume of $659,164, has already exchanged hands today.
Shares of Acology, Inc. are rallying Monday, after the company laid out plans for massive expansion. The company announced that it is finalizing its purchase of the 13,000-sq-ft. in Southern California. The new building will house a couple of new business divisions: Hydroponics Products and Vendor Connect Program. Management has signed a new Director of Sales and eight other sales executives. Here is the full press release detailing of the major expansion:
Acology, Inc. Press Release:
CORONA, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) — In response to rapidly increasing sales of all products across the globe Acology, Inc. (OTC PINK:ACOL) announced today that it is in the process of finalizing the purchase of a 13,000-sq.ft. building in Southern California. Several planned production expansions, including the creation of a new Hydroponic Products Division, a Consumer Services Division, expanded studio, artwork and printing operations and new Vendor Connect Program are all in the works. Plans to complete this expansion by April 1 are now proceeding.
In addition, Acology executives are finalizing contracts with a new Director of Sales and 8 additional sales executives to staff its new expanded headquarters in Corona, California. This expansion will allow Acology to reach 40,000 potential customers every month.
Since the end of last year and the beginning of this year Acology has seen its global sales surge. Acology executives intend to accelerate the momentum throughout their product lines by focusing additional man-power on these expanding markets. Acology anticipates product-sales growth to escalate from its current level to 200 or 300% in the next 3 to 5 years. Current sales of hydroponic products in the US generated more than $650M in 2016 and experts indicate that number will grow in the next several years by 30 to 40% annually. Along with continued growth in the sales of its other medical and cannabis-centered products, conservative estimates are that hydroponic products alone could potentially add $5M net to Acology’s bottom line the next 2 years.
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to firstname.lastname@example.org or call (844) ACOLOGY (844-226-5649). Acology can also be accessed through its social media accounts on Twitter and Instagram at @Acologyinc.
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.